KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Gross Margin (2016 - 2025)

Amgen has reported Gross Margin over the past 17 years, most recently at 178.54% for Q4 2025.

  • Quarterly results put Gross Margin at 178.54% for Q4 2025, up 21800.0% from a year ago — trailing twelve months through Dec 2025 was 109.74% (up 4821.0% YoY), and the annual figure for FY2025 was 96.43%, up 3490.0%.
  • Gross Margin for Q4 2025 was 178.54% at Amgen, up from 96.56% in the prior quarter.
  • Over the last five years, Gross Margin for AMGN hit a ceiling of 178.54% in Q4 2025 and a floor of 280.61% in Q4 2022.
  • Median Gross Margin over the past 5 years was 74.95% (2021), compared with a mean of 61.01%.
  • Biggest five-year swings in Gross Margin: crashed -35552bps in 2022 and later surged 34264bps in 2023.
  • Amgen's Gross Margin stood at 74.91% in 2021, then plummeted by -475bps to 280.61% in 2022, then soared by 122bps to 62.03% in 2023, then crashed by -164bps to 39.46% in 2024, then soared by 553bps to 178.54% in 2025.
  • The last three reported values for Gross Margin were 178.54% (Q4 2025), 96.56% (Q3 2025), and 67.2% (Q2 2025) per Business Quant data.